Bosentan is
High-Yield Explanation
It is a dual endothelial receptor antagonist. FDA has approved the use of Bosentan for Raynaud's phenomenan, pulmonary aery hypeension. Ref: HL Sharma 3rd ed,Vasoactive peptides
Related Pharmacology MCQs
Which of the following is glucocoicoid synthesis inhibitor?
General
At a high altitude of 3000 m, a person complains of breathlessness. All of the following can...
General
All of the following drugs act on cell membrane except:
General
A non-competitive inhibitor of an enzyme?
General
Which of the following is a phase I metabolic reaction?
General